TNFSF13 抗体
(Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of this gene have been identified\; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| TNFSF13 抗体 (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 | 犬 | 小鼠 Monoclonal |
|
|
|
| TNFSF13 抗体 | 犬 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (Biotin) | 人 | 山羊 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 96-240) | 大鼠 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 105-250) | Cow | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 96-241) | 小鼠 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 | 人, 小鼠 | 大鼠 Monoclonal |
|
|
|
| TNFSF13 抗体 (2nd Extracellular Domain) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (Extracellular Domain) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (Middle Region) | 人, 大鼠, 犬, Cow, Pig, 马, 兔, 山羊 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 1-250) | 人 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| TNFSF13 抗体 (AA 93-250) | 猴 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 93-250) | 猕猴 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 92-250) | 犬 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 92-250) | 犬 | 小鼠 Monoclonal |
|
|
|
| TNFSF13 抗体 (AA 1-250) | 人 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 1-250) (APC) | 人 | 兔 Polyclonal |
|
|
|
| TNFSF13 抗体 (AA 1-250) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 犬
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 96-240
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 105-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 96-241
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- 2nd Extracellular Domain
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- EIA (Enzyme Immunoassay: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Extracellular Domain
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 大鼠, 犬, Cow, Pig, 马, 兔, 山羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 21T94
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 93-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 猕猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 93-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 92-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 犬
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 92-250
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-250
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-250
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 1-250
Latest Publications for our TNFSF13 抗体
: "Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion." in: Oncogenesis, Vol. 7, Issue 6, pp. 45, (2018) (PubMed).
: "Macrophages induce differentiation of plasma cells through CXCL10/IP-10." in: The Journal of experimental medicine, Vol. 209, Issue 10, pp. 1813-23, S1-2, (2012) (PubMed).
: "Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas." in: Blood, Vol. 117, Issue 25, pp. 6856-65, (2011) (PubMed).
: "Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow." in: Blood, Vol. 118, Issue 7, pp. 1838-44, (2011) (PubMed).
: "Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas." in: BMC cancer, Vol. 8, pp. 76, (2008) (PubMed).
: "Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia." in: Immunology, Vol. 118, Issue 3, pp. 281-92, (2006) (PubMed).
: "BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone." in: Blood, Vol. 103, Issue 8, pp. 3148-57, (2004) (PubMed).
: "BAFF AND APRIL: a tutorial on B cell survival." in: Annual review of immunology, Vol. 21, pp. 231-64, (2003) (PubMed).
: "APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity." in: Nature immunology, Vol. 1, Issue 3, pp. 252-6, (2001) (PubMed).
: "APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death." in: Cancer research, Vol. 60, Issue 4, pp. 1021-7, (2000) (PubMed).
: "Macrophages induce differentiation of plasma cells through CXCL10/IP-10." in: The Journal of experimental medicine, Vol. 209, Issue 10, pp. 1813-23, S1-2, (2012) (PubMed).
: "Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas." in: Blood, Vol. 117, Issue 25, pp. 6856-65, (2011) (PubMed).
: "Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow." in: Blood, Vol. 118, Issue 7, pp. 1838-44, (2011) (PubMed).
: "Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas." in: BMC cancer, Vol. 8, pp. 76, (2008) (PubMed).
: "Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia." in: Immunology, Vol. 118, Issue 3, pp. 281-92, (2006) (PubMed).
: "BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone." in: Blood, Vol. 103, Issue 8, pp. 3148-57, (2004) (PubMed).
: "BAFF AND APRIL: a tutorial on B cell survival." in: Annual review of immunology, Vol. 21, pp. 231-64, (2003) (PubMed).
: "APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity." in: Nature immunology, Vol. 1, Issue 3, pp. 252-6, (2001) (PubMed).
: "APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death." in: Cancer research, Vol. 60, Issue 4, pp. 1021-7, (2000) (PubMed).
Aliases for TNFSF13 抗体
TNF superfamily member 13 (TNFSF13) 抗体tumor necrosis factor (ligand) superfamily, member 13 (Tnfsf13) 抗体
acidic leucine-rich nuclear phosphoprotein 32 family member B (LOC494442) 抗体
tumor necrosis factor (ligand) superfamily, member 13 (tnfsf13) 抗体
TNF superfamily member 13 (Tnfsf13) 抗体
tumor necrosis factor (ligand) superfamily, member 13 (TNFSF13) 抗体
2310026N09Rik 抗体
ANP32B 抗体
APRIL 抗体
April 抗体
april 抗体
CD256 抗体
SLAN 抗体
TALL-2 抗体
TALL2 抗体
Tall2 抗体
tnf13 抗体
TNLG7B 抗体
TRDL-1 抗体
Trdl1 抗体
ZTNF2 抗体
您还需要查找其他产品吗？
You are here:
